Folate	B:C0178638
-	O
based	O
single	O
cell	I:C0597452
screening	I:C0597452
using	O
surface	O
enhanced	I:C0037815
Raman	I:C0037815
microimaging	I:C0037815
.	O

Folate	O
-	O
based	O
single	B:C0597452
cell	I:C0597452
screening	I:C0597452
using	O
surface	O
enhanced	I:C0037815
Raman	I:C0037815
microimaging	I:C0037815
.	O

Folate	O
-	O
based	O
single	O
cell	I:C0597452
screening	I:C0597452
using	O
surface	B:C0037815
enhanced	I:C0037815
Raman	I:C0037815
microimaging	I:C0037815
.	O

Recent	O
progress	O
in	O
nanotechnology	O
and	O
its	O
application	O
to	O
biomedical	B:C0005540
settings	I:C0005540
have	O
generated	O
great	O
advantages	O
in	O
dealing	O
with	O
early	O
cancer	I:C2350269
diagnosis	I:C2350269
.	O

Recent	O
progress	O
in	O
nanotechnology	O
and	O
its	O
application	O
to	O
biomedical	O
settings	I:C0005540
have	O
generated	O
great	O
advantages	O
in	O
dealing	O
with	O
early	B:C2350269
cancer	I:C2350269
diagnosis	I:C2350269
.	O

The	O
identification	O
of	O
the	O
specific	O
properties	O
of	O
cancer	B:C0334227
cells	I:C0334227
,	O
such	O
as	O
the	O
expression	O
of	O
particular	O
plasma	O
membrane	I:C0007603
molecular	O
receptors	I:C1513401
,	O
has	O
become	O
crucial	O
in	O
revealing	O
the	O
presence	O
and	O
in	O
assessing	O
the	O
stage	O
of	O
development	O
of	O
the	O
disease	O
.	O

The	O
identification	O
of	O
the	O
specific	O
properties	O
of	O
cancer	O
cells	I:C0334227
,	O
such	O
as	O
the	O
expression	O
of	O
particular	O
plasma	B:C0007603
membrane	I:C0007603
molecular	O
receptors	I:C1513401
,	O
has	O
become	O
crucial	O
in	O
revealing	O
the	O
presence	O
and	O
in	O
assessing	O
the	O
stage	O
of	O
development	O
of	O
the	O
disease	O
.	O

The	O
identification	O
of	O
the	O
specific	O
properties	O
of	O
cancer	O
cells	I:C0334227
,	O
such	O
as	O
the	O
expression	O
of	O
particular	O
plasma	O
membrane	I:C0007603
molecular	B:C1513401
receptors	I:C1513401
,	O
has	O
become	O
crucial	O
in	O
revealing	O
the	O
presence	O
and	O
in	O
assessing	O
the	O
stage	O
of	O
development	O
of	O
the	O
disease	O
.	O

Here	O
we	O
report	O
a	O
single	B:C0597452
cell	I:C0597452
screening	I:C0597452
approach	O
based	O
on	O
Surface	O
Enhanced	I:C0037815
Raman	I:C0037815
Scattering	I:C0037815
(	I:C0037815
SERS	I:C0037815
)	I:C0037815
microimaging	I:C0037815
.	O

Here	O
we	O
report	O
a	O
single	O
cell	I:C0597452
screening	I:C0597452
approach	O
based	O
on	O
Surface	B:C0037815
Enhanced	I:C0037815
Raman	I:C0037815
Scattering	I:C0037815
(	I:C0037815
SERS	I:C0037815
)	I:C0037815
microimaging	I:C0037815
.	O

We	O
fabricated	O
a	O
SERS	B:C0037815
-	I:C0037815
labelled	I:C0037815
nanovector	O
based	O
on	O
the	O
biofunctionalization	O
of	O
gold	O
nanoparticles	O
with	O
folic	O
acid	I:C0016410
.	O

We	O
fabricated	O
a	O
SERS	O
-	I:C0037815
labelled	I:C0037815
nanovector	O
based	O
on	O
the	O
biofunctionalization	O
of	O
gold	O
nanoparticles	O
with	O
folic	B:C0016410
acid	I:C0016410
.	O

After	O
treating	B:C0007634
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	I:C0007600
lines	I:C0007600
(	O
cancer	O
HeLa	I:C0018873
and	O
PC	O
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	O
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	I:C2955669
proteins	I:C2955669
.	O

After	O
treating	O
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	B:C0007600
cell	I:C0007600
lines	I:C0007600
(	O
cancer	O
HeLa	I:C0018873
and	O
PC	O
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	O
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	I:C2955669
proteins	I:C2955669
.	O

After	O
treating	O
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	I:C0007600
lines	I:C0007600
(	O
cancer	B:C0018873
HeLa	I:C0018873
and	O
PC	O
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	O
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	I:C2955669
proteins	I:C2955669
.	O

After	O
treating	O
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	I:C0007600
lines	I:C0007600
(	O
cancer	O
HeLa	I:C0018873
and	O
PC	B:C3890720
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	O
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	I:C2955669
proteins	I:C2955669
.	O

After	O
treating	O
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	I:C0007600
lines	I:C0007600
(	O
cancer	O
HeLa	I:C0018873
and	O
PC	O
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	B:C0022567
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	O
binding	I:C2955669
proteins	I:C2955669
.	O

After	O
treating	O
the	I:C0007634
cells	I:C0007634
with	O
the	O
nanovector	O
,	O
we	O
were	O
able	O
to	O
distinguish	O
three	O
different	O
cell	O
populations	O
from	O
different	O
cell	I:C0007600
lines	I:C0007600
(	O
cancer	O
HeLa	I:C0018873
and	O
PC	O
-	I:C3890720
3	I:C3890720
,	O
and	O
normal	O
HaCaT	I:C0022567
lines	I:C0022567
)	O
,	O
suitably	O
chosen	O
for	O
their	O
different	O
expressions	O
of	O
folate	B:C2955669
binding	I:C2955669
proteins	I:C2955669
.	O

The	O
nanovector	O
,	O
indeed	O
,	O
binds	O
much	O
more	O
efficiently	O
on	O
cancer	B:C0334227
cell	I:C0334227
lines	I:C0334227
than	O
on	O
normal	O
ones	O
,	O
resulting	O
in	O
a	O
higher	O
Surface	O
Enhanced	I:C0037815
Raman	I:C0037815
Scattering	I:C0037815
signal	O
measured	O
on	O
cancer	O
cells	I:C0334227
.	O

The	O
nanovector	O
,	O
indeed	O
,	O
binds	O
much	O
more	O
efficiently	O
on	O
cancer	O
cell	I:C0334227
lines	I:C0334227
than	O
on	O
normal	O
ones	O
,	O
resulting	O
in	O
a	O
higher	O
Surface	B:C0037815
Enhanced	I:C0037815
Raman	I:C0037815
Scattering	I:C0037815
signal	O
measured	O
on	O
cancer	O
cells	I:C0334227
.	O

The	O
nanovector	O
,	O
indeed	O
,	O
binds	O
much	O
more	O
efficiently	O
on	O
cancer	O
cell	I:C0334227
lines	I:C0334227
than	O
on	O
normal	O
ones	O
,	O
resulting	O
in	O
a	O
higher	O
Surface	O
Enhanced	I:C0037815
Raman	I:C0037815
Scattering	I:C0037815
signal	O
measured	O
on	O
cancer	B:C0334227
cells	I:C0334227
.	O

These	O
results	O
pave	O
the	O
way	O
for	O
applications	O
in	O
single	B:C0597452
cell	I:C0597452
diagnostics	I:C0597452
and	O
,	O
potentially	O
,	O
in	O
theranostics	O
.	O

These	O
results	O
pave	O
the	O
way	O
for	O
applications	O
in	O
single	O
cell	I:C0597452
diagnostics	I:C0597452
and	O
,	O
potentially	O
,	O
in	O
theranostics	B:C4046052
.	O

